Cite
Beyond Neutralizing Antibody Levels: The Epitope Specificity of Antibodies Induced by National Institutes of Health Monovalent Dengue Virus Vaccines
MLA
Bhumi Patel, et al. “Beyond Neutralizing Antibody Levels: The Epitope Specificity of Antibodies Induced by National Institutes of Health Monovalent Dengue Virus Vaccines.” The Journal of Infectious Diseases, vol. 220, no. 2, Mar. 2019, pp. 219–27. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....9bb8a8b78fe4c5b285788bbc82e33f8d&authtype=sso&custid=ns315887.
APA
Bhumi Patel, Stephen S. Whitehead, Boyd Yount, Anna P. Durbin, Douglas G. Widman, Aravinda M. de Silva, Usha K. Nivarthi, Jesica Swanstrom, Ralph S. Baric, & Matthew J. Delacruz. (2019). Beyond Neutralizing Antibody Levels: The Epitope Specificity of Antibodies Induced by National Institutes of Health Monovalent Dengue Virus Vaccines. The Journal of Infectious Diseases, 220(2), 219–227.
Chicago
Bhumi Patel, Stephen S. Whitehead, Boyd Yount, Anna P. Durbin, Douglas G. Widman, Aravinda M. de Silva, Usha K. Nivarthi, Jesica Swanstrom, Ralph S. Baric, and Matthew J. Delacruz. 2019. “Beyond Neutralizing Antibody Levels: The Epitope Specificity of Antibodies Induced by National Institutes of Health Monovalent Dengue Virus Vaccines.” The Journal of Infectious Diseases 220 (2): 219–27. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....9bb8a8b78fe4c5b285788bbc82e33f8d&authtype=sso&custid=ns315887.